Professor Graham Devereux
MA, BM, BCh, MD, PhD, FRCP(Ed)
Personal Chair (Clinical)
Graham Devereux studied as an undergraduate at Cambridge and then Oxford Universities and trained in respiratory medicine in Newcastle, Nottingham and Aberdeen. Whilst in Newcastle he completed his MD thesis describing an epidemiological study of asthma prevalence in the North of England. After completing his clinical training in Aberdeen he completed a PhD thesis identifying antenatal influences on cord blood mononuclear cell responses. In addition to general clinical respiratory duties he has a subspecialist interest in airway diseases such as asthma, COPD and Cystic Fibrosis. His research interests include the identification of antenatal influences on the development of airways disease, but more recently he has become involved in clinical trials.
Research interests include the identification of antenatal influences on the development of airways disease and he is the principal investigator of the SEATON birth cohort study investigating associations between maternal diet during pregnancy and childhood asthma and allergy. He has published on the associations between childhood asthma and maternal diet, maternal smoking, parental occupation and fetal growth.
More recently he has become involved in clinical trials. he is Co-chief investigator for the NIHR HTA funded trial of low dose theophylline in COPD (TWICS) that has recruited 1578 people with COPD from 170 sites in the UK. He is working closely with Novabiotics to repurpose the drug cysteamine for use in people with cystic fibrosis, he has been/is chief investigator for several trials in this area. In the near future he will be co-chief investigator of the NIHR HTA funded trial of bisoprolol in COPD (BICS).
Page 1 of 12 Results 1 to 10 of 119
Maternal iron supplementation in pregnancy and asthma in the offspring: Follow-up of a randomised trial in FinlandEuropean Respiratory Journal, vol. 55, no. 6, 1902335Contributions to Journals: Letters
Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCTHealth technology assessment (Winchester, England), vol. 23, no. 37, pp. 1-146Contributions to Journals: Articles
Distinguishing wheezing phenotypes from infancy to adolescence: A pooled analysis of five birth cohortsAnnals of the American Thoracic Society, vol. 16, no. 7, pp. 868-876Contributions to Journals: Articles
Maternal vitamin D and E intakes in pregnancy and asthma to age 15 years: A cohort studyPediatric Pulmonology, vol. 54, no. 1, pp. 11-19Contributions to Journals: Articles
Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FASTHealth Technology Assessment, vol. 22, no. 70, pp. 1-82Contributions to Journals: Articles
Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical TrialJAMA, vol. 320, no. 15, pp. 1548-1559Contributions to Journals: Articles
Women and girls in resource poor countries experience much greater exposure to household air pollutants than men: Results from Uganda and EthiopiaEnvironment International, vol. 119, pp. 429-437Contributions to Journals: Articles
Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severityERJ Open Research, vol. 4, no. 2, pp. 1-11Contributions to Journals: Articles
Quadrupling Inhaled Gluococorticoid Dose To Abort Asthma ExacerbationsThe New England Journal of Medicine, vol. 378, no. 10, pp. 902-910Contributions to Journals: Articles
First trimester fetal size and prescribed asthma medication at 15 years of ageEuropean Respiratory Journal, vol. 51, no. 2, 1701509Contributions to Journals: Articles